Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $165.8700 (2.11%) ($161.7000 - $166.1300) on Tue. Mar. 6, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.51% (three month average) | RSI | 74 | Latest Price | $165.8700(2.11%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 1.9% a day on average for past five trading days. | Weekly Trend | LGND advances 1.1% a week on average for past two weeks. | Market Behavior | Normal for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(59%) IWO(57%) XBI(56%) IWC(54%) IWM(53%) | Factors Impacting LGND price | LGND will decline at least -0.755% in a week (0% probabilities). TLT(-15%) VIXM(-14%) UUP(-8%) GDXJ(-6%) IGOV(-4%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.755% (StdDev 1.51%) | Hourly BBV | 0 () | Intraday Trend | 1.4% | | | |
|
5 Day Moving Average | $158.75(4.49%) | 10 Day Moving Average | $156.53(5.97%) | 20 Day Moving Average | $155.31(6.8%) | To recent high | -1.4% | To recent low | 28% | Market Cap | $2.666b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |